Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma.

BACKGROUND Mass-forming type cholangiocarcinoma is a distinct from of cholangiocellular carcinoma, with pathologic and biologic behavior different from those of other types. The clinical consequences of these differences have never been clarified. METHODS Fifty-two consecutive patients (32 men and 20 women, mean age 62 years) with mass-forming type cholangiocarcinoma that had been treated with curative surgical resection between 1980 and 1998 were retrospectively evaluated. Long-term survival and disease-free survival were calculated, and univariate and multivariate analysis of various prognostic factors was conducted. RESULTS The 30-day postoperative mortality rate was 2%, and the overall and disease-free 5-year survival rates were 36% and 34%, respectively. Univariate analysis identified 5 significant risk factors for overall survival: surgical margin, lymph node metastasis, lymph node dissection, vascular invasion, and left-side location of the main tumor. Two risk factors were identified for disease-free survival: surgical margin and lymph node metastasis. Multivariate analysis confirmed that surgical margin, lymph node metastasis, and vascular invasion were independently significant variables for overall survival. CONCLUSIONS This is the first reported study on the effectiveness of liver resection for the treatment of mass-forming type cholangiocarcinoma, showing that surgical therapy can prolong survival if local radicality can be achieved and lymph-node metastases are absent.

[1]  M. Makuuchi,et al.  Accurate preoperative evaluation of liver mass lesions without fine‐needle biopsy , 1999, Hepatology.

[2]  M. Makuuchi,et al.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. , 1999, Archives of surgery.

[3]  S. Thung,et al.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. , 1998, Journal of the American College of Surgeons.

[4]  Randall G. Lee,et al.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. , 1998, Annals of surgery.

[5]  Randall G. Lee,et al.  Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma , 1997 .

[6]  M. Makuuchi,et al.  Measurement of liver volume and hepatic functional reserve as a guide to decision‐making in resectional surgery for hepatic tumors , 1997 .

[7]  S. Sheen-Chen,et al.  Surgical treatment of cholangiocarcinoma. , 1997, Hepato-gastroenterology.

[8]  M. Makuuchi,et al.  Intrahepatic cholangiocarcinoma presenting intrabile duct extension: clinicopathologic study of five resected cases. , 1997, Japanese journal of clinical oncology.

[9]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[10]  Y. Jan,et al.  Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. , 1996, Hepato-gastroenterology.

[11]  J. Fujimoto,et al.  Clinicopathologic spectrum of resected extraductal mass‐forming intrahepatic cholangiocarcinoma , 1995, Cancer.

[12]  Y. Konishi,et al.  Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. , 1995, Gastroenterology.

[13]  A. Rahmouni,et al.  Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. , 1995, Archives of surgery.

[14]  S. Kawasaki,et al.  Criteria for safe hepatic resection. , 1995, American journal of surgery.

[15]  O. Matsui,et al.  Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis. , 1995, The American journal of gastroenterology.

[16]  Y. Konishi,et al.  Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma , 1994, Journal of gastroenterology and hepatology.

[17]  S. Kawasaki,et al.  Radical operation after portal embolization for tumor of hilar bile duct. , 1994, Journal of the American College of Surgeons.

[18]  K. Leung,et al.  Ultrasonography during liver resection for hepatocellular carcinoma , 1993, The British journal of surgery.

[19]  Y. Nakanuma,et al.  Cell Kinetic and morphological studies of human cholangiocellular carcinoma , 1993, Acta pathologica japonica.

[20]  A. Nakao,et al.  Expression of HLA‐DR in intrahepatic cholangiocarcinoma , 1992, Cancer.

[21]  M. Makuuchi,et al.  Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. , 1992, Surgery.

[22]  M. Makuuchi,et al.  The value of ultrasonography for hepatic surgery. , 1991, Hepato-gastroenterology.

[23]  R. Wiesner,et al.  Cholangiocarcinoma complicating primary sclerosing cholangitis. , 1991, Annals of Surgery.

[24]  M. Makuuchi,et al.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.

[25]  A. Lok,et al.  Long‐term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features , 1990, Hepatology.

[26]  R. Peters,et al.  Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .

[27]  T Nakajima,et al.  A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. , 1988, Human pathology.

[28]  Pao-Huei Chen,et al.  Cholangiocarcinoma in Hepatolithiasis , 1984, Journal of clinical gastroenterology.

[29]  Y. Kawarada,et al.  Cholangiocellular carcinoma of the liver. , 1984, American journal of surgery.

[30]  K. Weinbren,et al.  Pathological aspects of cholangiocarcinoma , 1983, The Journal of pathology.

[31]  M. Kojiro,et al.  Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy‐proven cases , 1977, Cancer.

[32]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[33]  J. V. van Heerden,et al.  Cancer of the Bile Ducts Associated with Ulcerative Colitis , 1975, Annals of surgery.

[34]  J. Belamarić,et al.  Intrahepatic bile duct carcinoma and C. sinensis infection in Hong Kong , 1973, Cancer.

[35]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[36]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .